liver-infiltrating lymphocytes 4 of patients with chronic hepa-A cytotoxic T lymphocyte (CTL) response to the hepatitis C, the role of CTL responses in HCV infection is untitis C virus (HCV) nucleoprotein residues 88-96 that are known. HCV infection frequently persists and is implicated the minimal
Hepatitis C virus – T-cell responses and viral escape mutations
✍ Scribed by Danijela Petrovic; Eugene Dempsey; Derek G. Doherty; Dermot Kelleher; Aideen Long
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 399 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Hepatitis C virus (HCV) is a small, enveloped RNA virus and the number of HCV‐infected individuals worldwide is estimated to be approximately 170 million. Most HCV infections persist, with up to 80% of all cases leading to chronic hepatitis associated with liver fibrosis, cirrhosis, and hepatocellular carcinoma. HCV–host interactions have a crucial role in viral survival, persistence, pathogenicity of infection, and disease progression. Maintenance of a vigorous, sustained cellular immune response recognizing multiple epitopes is essential for viral clearance. To escape immune surveillance, HCV alters its epitopes so that they are no‐longer recognized by T cells and neutralizing antibodies, in addition to interfering with host cell cellular components and signaling pathways. The generation of escape variants is one of the most potent immune evasion strategies utilized by HCV. A large body of evidence suggests that single or multiple mutations within HLA‐restricted epitopes contribute to viral immune escape and establishment of viral persistence. Further elucidation of the molecular mechanisms underlying immune escape will aid in the design of novel vaccines and therapeutics for the disease.
📜 SIMILAR VOLUMES
Patients with chronic renal failure undergoing hemodialysis who are infected with hepatitis C virus (HCV) may test consistently anti-HCV negative. Because CD4(+) T-cells provide help for antibody production virus-specific effector CD4(+) T-cell responses were investigated in relation to anti-HCV pos
et al., 1 published in the January issue of Liver Transplantation, describing 2 cases of spontaneously cleared hepatitis C virus (HCV) infection in human immunodeficiency virus-coinfected patients early after liver transplantation. The cause for HCV clearance in those cases remained unclear. We rece
¨b-37 months [range, 28 months-23 years] as documented by the first ingen, Tu ¨bingen, Germany.